Clinical Trial Update: SubCutaneous (SC) Versus Intravenous (IV) Granulocyte Colony Stimulating Factors (G-CSF) for the Treatment of Neutropenia in Hospitalized Haemato-oncological Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing subcutaneous versus intravenous administration of granulocyte colony-stimulating factor (G-CSF) for neutropenia in hospitalized leukem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• Granulocyte Colony-Stimulating Factor (G-CSF) (G-CSF)

Snippet

Sponsor: Rabin Medical Center | Conditions: Leukemia | Phase 4 | Status: TERMINATED